Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : LPH-5
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Biotrial
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate LPH-5 in Healthy Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 09, 2024
Lead Product(s) : LPH-5
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Biotrial
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : LPH-5
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Beckley Psytech
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the terms of the agreement Beckley Psytech will jointly fund continuing development of the Lophora pipeline including it's lead candidate LPH-5 and collaborate broadly on R&D.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
November 05, 2022
Lead Product(s) : LPH-5
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Beckley Psytech
Deal Size : Undisclosed
Deal Type : Collaboration